Xiaojuan Xiao

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 12

Top Topics

Chronic Lymphocytic Leukemia

Multiple Myeloma

Top Venues

Cell death & disease

British journal of haematology

Biotechnology letters

This page only lists publications with an associated author ORCID identifier.

Publications

Yanpeng Wang, Yuanliang Peng, Chaoying Yang, Dehui Xiong, Zeyuan Wang, Hongling Peng, Xusheng Wu, Xiaojuan Xiao, Jing Liu
Single-cell sequencing analysis of multiple myeloma heterogeneity and identification of new theranostic targets. Cell death & disease 15 (9) (2024)
Abdul Aziz, Haiqin Wang, Yanpeng Wang, Zhenzhen Li, Chaoying Yang, Zekang Ma, Xiaojuan Xiao, Jing Liu
Periplocin Overcomes Bortezomib Resistance by Suppressing the Growth and Down-Regulation of Cell Adhesion Molecules in Multiple Myeloma. Cancers 15 (5) (2023)
Yu Zhu, Zi Wang, Yanan Li, Hongling Peng, Jing Liu, Ji Zhang, Xiaojuan Xiao
The Role of CREBBP/EP300 and Its Therapeutic Implications in Hematological Malignancies. Cancers 15 (4) (2023)
Abdul Aziz, Haiqin Wang, Yanpeng Wang, Zhenzhen Li, Chaoying Yang, Zekang Ma, Xiaojuan Xiao, Jing Liu
Periplocin Overcomes Bortezomib Resistance by Suppressing the Growth and Down-Regulation of Cell Adhesion Molecules in Multiple Myeloma. Cancers 15 (5) (2023)
Yu Zhu, Zi Wang, Yanan Li, Hongling Peng, Jing Liu, Ji Zhang, Xiaojuan Xiao
The Role of CREBBP/EP300 and Its Therapeutic Implications in Hematological Malignancies. Cancers 15 (4) (2023)
Wancheng Guo, Daomiao Liang, Peilong Wang, Le Yin, Huifang Zhang, Cheng Xing, Zineng Huang, Yinghua Wu, Heng Li, Zhao Cheng, Xiaojuan Xiao, Jing Liu, Zhihua Wang, Hongling Peng
HIF-PH Encoded by EGLN1 Is a Potential Therapeutic Target for Chronic Lymphocytic Leukemia. Pharmaceuticals (Basel, Switzerland) 15 (6) (2022)
Zhaoping Liu, Pan Wang, Shunling Yuan, Yanyan Wang, Pengfei Cao, Feng Wen, Hui Li, Lin Zhu, Long Liang, Zi Wang, Bin Hu, Fuxiang Zheng, Jing Liu, Xiaojuan Xiao, Ji Zhang
LncRNA BC200/miR-150-5p/MYB positive feedback loop promotes the malignant proliferation of myelodysplastic syndrome. Cell death & disease 13 (2) (2022)
Han Gong, Heng Li, Qin Yang, Guangxiong Zhang, Hong Liu, Zekang Ma, Hong-Ling Peng, Ling Nie, Xiaojuan Xiao, Jing Liu
A Ferroptosis Molecular Subtype-Related Signature for Predicting Prognosis and Response to Chemotherapy in Patients with Chronic Lymphocytic Leukemia. BioMed research international 2022 (2022)
Hui Yi, Xiaokai Shen, Haiqin Wang, Saiqun Luo, Wancheng Guo, Peng Chen, Lei Hu, Long Liang, Yanfei Gong, Xiaojuan Xiao, Jing Liu
Protein mass spectrometry reveals lycorine exerting anti-multiple-myeloma effect by acting on VDAC2 and causing mitochondrial abnormalities. Biotechnology letters 43 (3) (2021)
Wancheng Guo, Haiqin Wang, Peng Chen, Xiaokai Shen, Boxin Zhang, Jing Liu, Hongling Peng, Xiaojuan Xiao
Identification and Characterization of Multiple Myeloma Stem Cell-Like Cells. Cancers 13 (14) (2021)
Long Liang, Yanjuan He, Haiqin Wang, Hui Zhou, Ling Xiao, Mao Ye, Yijin Kuang, Saiqun Luo, Yuna Zuo, Peifu Feng, Chaoying Yang, Wenjie Cao, Taohua Liu, Mridul Roy, Xiaojuan Xiao, Jing Liu
The Wee1 kinase inhibitor MK1775 suppresses cell growth, attenuates stemness and synergises with bortezomib in multiple myeloma. British journal of haematology 191 (1) (2020)
Haiqin Wang, Yanfei Gong, Long Liang, Ling Xiao, Hui Yi, Mao Ye, Mridul Roy, Jiliang Xia, Wen Zhou, Chaoying Yang, Xiaokai Shen, Boxin Zhang, Zhenzhen Li, Jing Liu, Hui Zhou, Xiaojuan Xiao
Lycorine targets multiple myeloma stem cell-like cells by inhibition of Wnt/β-catenin pathway. British journal of haematology 189 (6) (2020)